ACXP
Acurx Pharmaceuticals, Inc.Company with tickers: ACXP
CIK
1736243
CUSIP
00510M203
Shares Outstanding
4,297,738
13F Activity (30d)
16 filings
14 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2025-01-06 | LUCI DAVID P |
Director, President and CEO, 10% Owner | Other | 15,083 |
| 2025-01-06 | Donohue James J. |
Director | Buy | 9,852 |
| 2025-01-06 | DEAN JACK H |
Director | Buy | 9,852 |
| 2025-01-06 | DEAN JACK H |
Director | Buy | 9,852 |
| 2025-01-06 | DEAN JACK H |
Director | Other | 5,770 |
| 2025-01-06 | LUCI DAVID P |
Director, President and CEO, 10% Owner | Buy | 49,261 |
| 2025-01-06 | Donohue James J. |
Director | Buy | 9,852 |
| 2025-01-06 | DELUCCIA ROBERT J |
Director, 10% Owner | Other | 3,847 |
| 2025-02-05 | LUCI DAVID P |
Director, President and CEO, 10% Owner | Award | 250,000 |
| 2025-02-05 | Shawah Robert G. |
Chief Financial Officer | Award | 145,500 |
| 2025-02-05 | DELUCCIA ROBERT J |
Director, 10% Owner | Award | 250,000 |
| 2026-04-20 | DELUCCIA ROBERT J |
Director, 10% Owner | Award | 37,100 |
| 2026-04-20 | Sailer Carl |
Director | Award | 2,150 |
| 2026-04-20 | LUCI DAVID P |
Director, President and CEO, 10% Owner | Award | 37,100 |
| 2026-04-20 | HARRISON THOMAS L |
Director | Award | 2,150 |
| 2026-04-20 | Shawah Robert G. |
Chief Financial Officer | Award | 25,900 |
| 2026-04-20 | Scodari Joseph C |
Director | Award | 2,150 |
| 2026-04-20 | Donohue James J. |
Director | Award | 2,150 |
| 2026-04-20 | DEAN JACK H |
Director | Award | 2,150 |
Showing 101–119 of 119 transactions